Surgery for Obesity and Related Diseases · Oct 14, 2026

Long-term follow-up of postbariatric surgery mortality rates: a meta-analysis

By He K, Cunningham MH, Jia IT et al.

BACKGROUND: Bariatric surgery effectively treats obesity and related co-morbidities, but the magnitude and durability of long-term mortality benefit compared with nonsurgical management remain poorly characterized. OBJECTIVES: To synthesize the longest-term available mortality data comparing bariatric surgery with nonsurgical weight management in patients with obesity. SETTING: Large-scale meta-analysis. METHODS: A meta-analysis was conducted of studies published between 2000 and 2025 reporting mortality outcomes after sleeve gastrectomy or Roux-en-Y gastric bypass (RYGB) compared with control cohorts with obesity. Survival at all available postoperative intervals was evaluated. Mixed-effects meta-regression assessed patient-specific modifiers of mortality, whereas random-effects meta-analyses evaluated timepoint-specific mortality and cause-of-death differences. RESULTS: Thirty-four studies including 449,957 patients were analyzed. Early postoperative mortality was low across all cohorts. Over a longer follow-up, bariatric surgery was associated with lower cumulative mortality compared with nonsurgical controls. At 7 years, pooled mortality was 2.64% in controls, 1.64% following RYGB, and .76% following sleeve gastrectomy. At 12 years, mortality remained lower after RYGB (4.34%) compared with controls (7.11%). Among patients with type 2 diabetes, mortality at 5 years was substantially lower following RYGB compared with diabetic controls (2.29% versus 11.0%). Cause-of-death analysis demonstrated fewer cancer-related deaths after RYGB (odds ratio, .46; 95% confidence interval, .31-.70) but higher proportions of deaths due to accidents, substance abuse, and suicide. CONCLUSIONS: Bariatric surgery is associated with durable reductions in long-term mortality compared with nonsurgical management of obesity, particularly among patients with type 2 diabetes, supporting its role as an important intervention for improving long-term survival in severe obesity.

doi.org/10.1016/j.soard.2026.10.009PubMed 43026104Interventions

AgingResearch.News